Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Dan Duncan Comprehensive Cancer Center, Baylor College of Medicine

1 abstract

Abstract
Dosing patterns and treatment patterns in real-world patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who received FOLFIRINOX in the first line.
Org: Genesis Research, Ipsen Biopharmaceuticals, Inc., Dan Duncan Comprehensive Cancer Center, Baylor College of Medicine,